The Symphera Story
Founded in 2023, Symphera emerged from the innovative minds at TU Munich and UnternehmerTUM, drawing inspiration from the University Hospital in Basel. The company’s vision is clear: to streamline surgical workflows and significantly improve patient outcomes post-operation.
At the helm of Symphera are a trio of talented co-founders: Nico Weigand, Conrad Heid, and Philipp Preißler An engineering expert with a strong network in the MedTech industry, adding a robust technical foundation to the team and Thomas Wegele Technical Developers.Weigand brings a wealth of experience from high-tech startups and management consulting, while Heid offers insights from his time as a surgical resident at the University Hospital Basel. Preißler, with his engineering background and connections within the medtech ecosystem, complements the team’s expertise.
A Revolutionary Solution
Symphera’s innovative approach to laparoscopic surgery centers around automating tool-switching. Their advanced surgical systems eliminate the need for manual instrument changes, allowing surgeons to maintain uninterrupted focus throughout the procedure. By simply pressing a button, surgeons can seamlessly switch between instruments, akin to using a multi-pen.
This breakthrough technology promises to simplify surgical workflows, reduce operating times, and ultimately improve patient outcomes. Symphera’s all-in-one laparoscopic device is a first-of-its-kind innovation, setting it apart from competitors in the market.
Industry Recognition and Support
Symphera’s innovative solution has garnered significant attention and support from experts and institutions specializing in minimally invasive surgery. Renowned figures like Prof. Jacques Marescaux, Founder and President of IRCAD, and Dr. Jan Engels, Investment Manager at HTGF, have expressed their enthusiasm for Symphera’s potential to reshape the landscape of surgical procedures.
Funding Details
The €2.4 million seed funding round was led by High-Tech Gründerfonds (HTGF), a prominent early-stage investor in Europe. Additional investors included Bayern Kapital, CARMA FUND, UnternehmerTUM Funding for Innovators, Stern Stewart Ventures, IRCAD, and expert business angels.
Future Plans
With this fresh capital, Symphera plans to accelerate the development of their product, conduct preclinical tests, and prepare for the certification process. These crucial steps will bring their innovative technology closer to market, paving the way for a new era of laparoscopic surgery.
Symphera’s groundbreaking tool-switching technology has the potential to revolutionize the field of laparoscopic surgery. With the support of a strong investor consortium and a dedicated team, the company is well-positioned to improve surgical outcomes and enhance patient care.
Website : https://symphera.io/
der Conrad Heid, he is hands-on experience in laparoscopic surgery and over three years as a surgical resident at the University Hospital Basel, Nico Weigand Combines his experience from high-tech startups and management consulting with a solid engineering background, Philipp Preißler An engineering expert with a strong network in the MedTech industry, adding a robust technical foundation to the team and Thomas Wegele Technical Developers.
